Angios Biotech is an Austrian biotechnology company specializing in cell-based research focused on vascular diseases, utilizing induced pluripotent stem cells (iPSC) to develop novel therapies.

Angios Biotech

Angios FlexCo | 649 followers on LinkedIn. Novel approaches to vascular therapy | Angios is a biotechnology company, specializing in vascular research to improve patients&#39; lives all over the world. We are based in the beautiful city of Innsbruck. We strive to develop new treatments for challenging diabetic vascular diseases by pursuing pre-identified targets for diabetic retinopathy and by leveraging the vascular organoid model developed in the laboratories of our founders.

Senior Scientist

Azarakhsh Oladzad

Scientist & Lab Manager @ Angios GmbH | Ph.D. in Pharmaceutical Sciences & B.A. (MCI) in Business Administration | Digital Marketing enthusiast

Tanila Ben Haddou

Biotechnologin

Nicole Przysiecki

CEO & Founder bei Angios Flexco, Consultant to Life Sciences companies/investors

Gregor Wick

Angios FlexCo

Danke an alle, die uns bei der Langen Nacht der Forschung am 24.05 im CCB Innsbruck besucht haben! Wir sind begeistert, wie viele junge WissenschaftlerInnen sich für Organoidforschung interessieren.

Hands on with Angios at the Lange Nacht der Forschung!

Join us on Friday 24.05.2024 at the CCB Innsbruck for an exciting night of research.

Angios with partners from SWEEPICS consortium in our kick-off meeting in Lübeck. Check us out at www.sweepics.eu

Angios at the PhD Life science meeting in Innsbruck.

We are hiring! Check out the position on our website www.angios-bio.com

Europe Biotechnology Companies (Top 10K)

Medical Companies With Fewer Than 10 Employees (Top 10K)

European Union (EU) Medical Companies (Top 10K)

European Union (EU) Health Care Companies (Top 10K)

Angios is a biotechnology company, specializing in vascular research to provide solutions for diabetic retinopathy.

Innsbruck

Tirol

Austria

Europe

Angios

Lab-grown human blood vessels used for regenerative transplantation medicine, aiming to improve wound healing in diabetic patients by integrating with host vasculature.

Development of antibody-based treatments for diabetic vasculopathies in collaboration with Abcellera Biologics.

A platform designed to replace animal models for preclinical toxicity tests, using human-relevant models to better predict human responses.

United Kingdom

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 14, 2024 11:41 AM	843b6646
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 14, 2024 11:41 AM	24426b9e
crunchbase trigger	general	Nov 14, 2024 11:41 AM	6b376fc2
crunchbase profile	general	Nov 15, 2024 7:50 AM	d8222e3c
li profile	general	Nov 14, 2024 11:41 AM	731d0628
translate crunchbase fundingrounds	general	Nov 15, 2024 8:56 AM	6389e755
peers	general	Nov 14, 2024 11:41 AM	272f9cff
news basic	general	Nov 14, 2024 11:41 AM	05e0d592
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

ANGI

COM:ANGIOS-BIO

Angios Biotech